Newly diagnosed low- and high-risk prostate cancer patients seen during the same appointment by a urologist and radiation oncologist were more likely than patients in a nationwide cohort to choose evidence-based care, according to a study by researchers from The University of Texas MD Anderson Cancer Center, Houston.
MD Anderson and other U.S. cancer centers have developed a multidisciplinary approach to care designed to give prostate cancer patients a balanced presentation of all their treatment options.
Urologists are usually the first to see prostate cancer patients, followed at a later date by radiation oncologists or medical oncologists, according to study author Chad Tang, MD, of The University of Texas MD Anderson Cancer Center.
“When you have multidisciplinary practice, that means you have two physicians from different specialties at the same time, in the same clinic, seeing the patient either together or back to back,” Dr. Tang said.
The multidisciplinary approach allows simultaneous presentation of therapy choices, facilitating informed decision-making and expediting the time to treatment initiation, according to the study, which was published online ahead of print in Cancer (Nov. 19, 2019).
The authors compared the treatment choices of 4,451 newly diagnosed prostate cancer patients presenting to MD Anderson multidisciplinary prostate cancer clinics from 2004 to 2016 to 392,710 prostate cancer patients nationwide diagnosed between 2004 and 2015 in the Surveillance, Epidemiology and End Results (SEER) database.
The authors found that 74% of men in the MD Anderson multidisciplinary group with low-risk disease received evidence-based nondefinitive therapy compared to 54% in the SEER cohort.